(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide

C19H23N3O5 — CID 54553203

IUPAC(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide
SMILESCc1ccc(C2(C)CCN([C@H](CN3C(=O)CCC3=O)C(=O)NO)C2=O)cc1
InChIInChI=1S/C19H23N3O5/c1-12-3-5-13(6-4-12)19(2)9-10-21(18(19)26)14(17(25)20-27)11-22-15(23)7-8-16(22)24/h3-6,14,27H,7-11H2,1-2H3,(H,20,25)/t14-,19?/m1/s1
InChIKeyZLIOINFBPGLEMO-MJTSIZKDSA-N
MW373.41 g/mol
LogP0.51
Rot. Bonds5

About (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide

(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide (PubChem CID 54553203) has the molecular formula C19H23N3O5 and a molecular weight of 373.41 g/mol. Its IUPAC name is (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide.

Molecular Properties

Compound Name(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide
PubChem CID54553203
Molecular FormulaC19H23N3O5
Molecular Weight373.41 g/mol
Exact Mass373.16
IUPAC Name(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide
SMILESCc1ccc(C2(C)CCN([C@H](CN3C(=O)CCC3=O)C(=O)NO)C2=O)cc1
InChIInChI=1S/C19H23N3O5/c1-12-3-5-13(6-4-12)19(2)9-10-21(18(19)26)14(17(25)20-27)11-22-15(23)7-8-16(22)24/h3-6,14,27H,7-11H2,1-2H3,(H,20,25)/t14-,19?/m1/s1
InChIKeyZLIOINFBPGLEMO-MJTSIZKDSA-N
XLogP0.51
TPSA107.02 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500373.41
LogP ≤ 50.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide?
The IUPAC name of (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide (CID 54553203) is (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide.
What is the SMILES notation for (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide?
The canonical SMILES for (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide is Cc1ccc(C2(C)CCN([C@H](CN3C(=O)CCC3=O)C(=O)NO)C2=O)cc1.
What is the InChIKey of (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide?
The InChIKey is ZLIOINFBPGLEMO-MJTSIZKDSA-N. The full InChI is InChI=1S/C19H23N3O5/c1-12-3-5-13(6-4-12)19(2)9-10-21(18(19)26)14(17(25)20-27)11-22-15(23)7-8-16(22)24/h3-6,14,27H,7-11H2,1-2H3,(H,20,25)/t14-,19?/m1/s1.
What are the key properties of (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide?
(2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide has a molecular weight of 373.41 g/mol, XLogP of 0.51, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-3-(2,5-dioxopyrrolidin-1-yl)-N-hydroxy-2-[3-methyl-3-(4-methylphenyl)-2-oxopyrrolidin-1-yl]propanamide is sourced from PubChem (CID 54553203), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).